Digoxin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00390 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 57 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Prinzmetal angina | KG + DL |
| 2 | duodenal obstruction | KG + DL |
| 3 | duodenal ulcer (disease) | KG + DL |
| 4 | duodenogastric reflux | KG + DL |
| 5 | obsolete susceptibility to ischemic stroke | KG + DL |
| 6 | hypoalphalipoproteinemia | KG + DL |
| 7 | homozygous familial hypercholesterolemia | KG + DL |
| 8 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 9 | thrombotic disease | KG + DL |
| 10 | stroke disorder | KG + DL |
| 11 | ABri amyloidosis | KG + DL |
| 12 | intracerebral hemorrhage | KG + DL |
| 13 | cavernous sinus thrombosis | KG + DL |
| 14 | lateral sinus thrombosis | KG + DL |
| 15 | brain stem infarction | KG + DL |
| 16 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 17 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 18 | cerebrovascular disorder | KG + DL |
| 19 | sick sinus syndrome 2, autosomal dominant | KG + DL |
| 20 | idiopathic granulomatous myositis | KG + DL |
| 21 | myositis fibrosa | KG + DL |
| 22 | tendinitis | KG + DL |
| 23 | sarcoglycanopathy | KG + DL |
| 24 | Wildervanck syndrome | KG + DL |
| 25 | non-inflammatory vasculopathy | KG + DL |
| 26 | cerebral artery occlusion | KG + DL |
| 27 | angiodysplasia | KG + DL |
| 28 | diabetic nephropathy | KG + DL |
| 29 | chronic renal failure syndrome | KG + DL |
| 30 | fibrocartilaginous embolism | KG + DL |
| 31 | venous thromboembolism | KG + DL |
| 32 | fibromyalgia | KG + DL |
| 33 | macrocephaly, dysmorphic facies, and psychomotor retardation | KG + DL |
| 34 | duodenitis | KG + DL |
| 35 | spinal cord ischemia | KG + DL |
| 36 | congenital renal artery stenosis | KG + DL |
| 37 | vascular insufficiency disorder | KG + DL |
| 38 | cerebral infarction | KG + DL |
| 39 | obsolete familial combined hyperlipidemia | KG + DL |
| 40 | ABeta amyloidosis | KG + DL |
| 41 | inclusion body myositis | KG + DL |
| 42 | transient ischemic attack (disease) | KG + DL |
| 43 | MRI defined brain infarct | KG + DL |
| 44 | vein disease | KG + DL |
| 45 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 46 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 47 | Braddock syndrome | KG + DL |
| 48 | malignant renovascular hypertension | KG + DL |
| 49 | malignant hypertensive renal disease | KG + DL |
| 50 | periodic paralysis with transient compartment-like syndrome | KG + DL |
(Showing top 50 of 57 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.